LONDON - Shionogi & Co., Ltd. (TYO:4507) has reported positive outcomes from its Phase 2a human challenge trial for an investigational oral antiviral candidate targeting Respiratory Syncytial Virus ...

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

GSK posted a better-than-expected fourth quarter on Wednesday and lifted its 2031 sales target to nearly $50 billion as the British drugmaker aims to invest heavily in its specialty medicines to ...

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

Once confirmed by the Senate, Kennedy—the most visible, outspoken, and influential anti-vaccination, anti-science quack ...

One of the primary issues new nurses face once they are allowed to work independently is managing a heavy workload and time ...

Louisiana’s flu season is in full swing, and cases are spiking. See the latest numbers and how you can stay healthy.

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...

Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused ...